Toray Medical Company Limited Sustainability Profile
Toray Medical Company Limited, a prominent player in the medical technology sector, is headquartered in Japan (JP) and operates extensively across Asia, Europe, and North America. Founded in 1926, the company has established itself as a leader in the development of advanced medical devices and pharmaceuticals, particularly in the fields of regenerative medicine and dialysis. Toray Medical is renowned for its innovative core products, including biocompatible dialysis membranes and cutting-edge surgical sutures, which are distinguished by their superior performance and safety profiles. The company’s commitment to research and development has led to significant milestones, positioning it as a trusted name in the healthcare industry. With a strong market presence and a focus on improving patient outcomes, Toray Medical continues to make strides in enhancing medical technologies globally.
DitchCarbon Score
How does Toray Medical Company Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Toray Medical Company Limited's score of 41 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Toray Medical Company Limited, headquartered in Japan (JP), currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Toray Industries, Inc., which may influence its climate commitments and emissions reporting. As of now, there are no documented reduction targets or climate pledges specific to Toray Medical Company Limited. However, emissions data and performance metrics may be inherited from its parent company, Toray Industries, Inc., which has established initiatives aimed at reducing carbon emissions. This includes participation in the Carbon Disclosure Project (CDP) and Climate Action 100+ (CA100), both of which are significant frameworks for corporate climate accountability. While specific emissions figures are not provided, Toray Medical's climate commitments may align with broader strategies set by Toray Industries, Inc. to enhance sustainability and reduce environmental impact. The absence of direct emissions data highlights the need for further transparency and commitment to climate action within the medical sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Scope 1 | 3,310,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 2 | 2,325,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 3 | 744,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 | 00,000,000,000 | 00,000,000,000 |
How Carbon Intensive is Toray Medical Company Limited's Industry?
How Carbon Intensive is Toray Medical Company Limited's Location?
Toray Medical Company Limited's Scope 3 Categories Breakdown
Toray Medical Company Limited's Scope 3 emissions, which increased by 66% last year and increased significantly since 2018, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 78% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 49% of Scope 3 emissions.
Top Scope 3 Categories
Toray Medical Company Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Toray Medical Company Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
